|
| |
NeoPharmNeoPharm is a pharmaceutical Company engaged in the research and development of drugs for the diagnosis and treatment of various forms of cancer. Presently the Company has several drugs which are in varying stages of development: BUdR(Broxuridine), liposome encapsulated doxorubicin ("LED"), liposome encapsulated paclitaxel ("LEP"), liposome encapsulated antisense oligodeoxynucleotide ("LE-AON" and with LED and LEP the "Liposome Products"), IL-13 PE38QQR ("IL-13") and Mesothelin SS-(dsFv)-PE38 ("Mesothelin Mab"). IL-13 and Mesothelin Mab are both Ligand Target Cytotoxins that specifically target cancer cells and leave normal cells unaffected.
| Contact Details: |
| 1850 Lakeside Drive |
| Waukegan |
| IL |
| 60085 |
| United States of America |
| Tel: | 847-887-0800 |
| Fax: | 847-887-9281 |
| Email: | investorrelations@neopharm.com |
| WWW: | www.neophrm.com/
|
|
Loading...
|
Recent Publications by NeoPharm: |  |
The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
The feasibility of an automated screening device that will analyze... | 17th December, 2008
| Neopharm Group and Ben-Gurion University, Beer Sheva, Israel.
| Food Drug Law J. 2008;63(3):701-11.
|
CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS.
OBJECTIVE: Cintredekin besudotox (CB), a recombinant cytotoxin consisting... | 2nd October, 2008
| The Cleveland Clinic Foundation, Cleveland, Ohio (Vogelbaum) Duke
| Neurosurgery. 2008 Sep 15.
DOI Direct Link |
Synthesis of 1,3- and 1,2-diphosphatidylglycerol.
A novel phosphonium salt methodology was utilized for the first time to... | 18th July, 2007
| NeoPharm, Inc., 1850 Lakeside Drive, Waukegan, IL 60085, USA.
| Lipids. 2007 Apr;42(3):291-6. Epub 2007 Feb 7.
DOI Direct Link |
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
Our objectives were to study the biological activity of a novel... | 28th October, 2006
| Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA.
| Anticancer Drugs. 2006 Jan;17(1):53-61.
|
A novel cationic cardiolipin analogue for gene delivery.
The optically active R and S isomers of cationic cardiolipin analogues... | 11th March, 2006
| NeoPharm, Inc, Waukegan, IL 60085, USA.
| Pharmazie. 2006 Jan;61(1):10-4.
|
→View more NeoPharm research publications. |
Press Releases on NeoPharm:
|
 |
| Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer |
29th June, 2009 |
Horizon Therapeutics, Inc. |
--Dr. Sherman also elected President of the Drug Information Association (DIA)--
NORTHBROOK, Ill., June 29 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company,
|
| Horizon Therapeutics Names Timothy P. Walbert as President and CEO |
24th July, 2008 |
Horizon Therapeutics, Inc. |
PALO ALTO, Calif., July 24 /PRNewswire/ -- Horizon Therapeutics, Inc., a
privately held biopharmaceutical company, today announced that Timothy P.
Walbert has been named president, chief executive
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1278 times since April 2007, the link to the organisation's website has been followed 193 times Recent Search Terms used to find this page: neopharm | Neopharm news | jeff sherman neol | NeoPharm | Chemipal and Neopharm | neopharm | Neopharm usa | neopharm company profile | neopharm 2009 cintredekin nda | Jeffrey W Sherman horizon theraputics email | . Search for more companies in Waukegan Search for more companies in IL This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for NeoPharm |
